SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-016081
Filing Date
2024-05-13
Accepted
2024-05-10 17:54:37
Documents
16
Period of Report
2024-05-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K atxi20240510_8k.htm   iXBRL 8-K 28039
2 EXHIBIT 1.1 ex_672055.htm EX-1.1 187894
3 EXHIBIT 5.1 ex_671968.htm EX-5.1 10391
  Complete submission text file 0001437749-24-016081.txt   412449

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA atxi-20240510.xsd EX-101.SCH 3409
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atxi-20240510_def.xml EX-101.DEF 11424
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxi-20240510_lab.xml EX-101.LAB 15310
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxi-20240510_pre.xml EX-101.PRE 11584
19 EXTRACTED XBRL INSTANCE DOCUMENT atxi20240510_8k_htm.xml XML 2848
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38114 | Film No.: 24936265
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)